Panbela Therapeutics, Inc. (PBLA)

USD 0.26

(-3.7%)

Long Term Debt Summary of Panbela Therapeutics, Inc.

  • Panbela Therapeutics, Inc.'s latest annual long term debt in 2023 was 4.19 Million USD , down -19.25% from previous year.
  • Panbela Therapeutics, Inc.'s latest quarterly long term debt in 2024 Q2 was 3.19 Million USD , down 0.0% from previous quarter.
  • Panbela Therapeutics, Inc. reported annual long term debt of 5.19 Million USD in 2022, down 0.0% from previous year.
  • Panbela Therapeutics, Inc. reported annual long term debt of - USD in 2021, down 0.0% from previous year.
  • Panbela Therapeutics, Inc. reported quarterly long term debt of 3.19 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Panbela Therapeutics, Inc. reported quarterly long term debt of 4.19 Million USD for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Panbela Therapeutics, Inc. (2023 - 2011)

Historical Annual Long Term Debt of Panbela Therapeutics, Inc. (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 4.19 Million USD -19.25%
2022 5.19 Million USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD -100.0%
2017 286 Thousand USD 0.0%
2016 - USD -100.0%
2015 3.07 Million USD 127334.73%
2014 2413.00 USD -62.64%
2013 6458.00 USD -21.71%
2012 8249.00 USD 115.38%
2011 3830.00 USD 0.0%

Peer Long Term Debt Comparison of Panbela Therapeutics, Inc.

Name Long Term Debt Long Term Debt Difference
America Great Health 1.12 Million USD -273.418%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. 1.29 Million USD -224.613%
Biora Therapeutics, Inc. 43.73 Million USD 90.411%
Bio-Path Holdings, Inc. 10 Thousand USD -41840.0%
Better Therapeutics, Inc. 10.34 Million USD 59.47%
Calithera Biosciences, Inc. 136 Thousand USD -2983.824%
Comera Life Sciences Holdings, Inc. 120.3 Thousand USD -3386.226%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. 8.69 Million USD 51.749%
Evelo Biosciences, Inc. 48.87 Million USD 91.42%
Evolutionary Genomics, Inc. 3.74 Million USD -12.027%
Finch Therapeutics Group, Inc. 28.4 Million USD 85.234%
Galera Therapeutics, Inc. 151.04 Million USD 97.223%
Innovation1 Biotech Inc. 218.99 Thousand USD -1815.077%
Kiromic BioPharma, Inc. 911.5 Thousand USD -360.121%
Molecular Templates, Inc. 9.74 Million USD 56.949%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD -124.073%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 19.06 Million USD 78.004%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 104.33 Million USD 95.98%
Statera Biopharma, Inc. 11.43 Million USD 63.311%
TRACON Pharmaceuticals, Inc. 732 Thousand USD -472.951%
Trevena, Inc. 35.23 Million USD 88.096%
Vaxxinity, Inc. 13.26 Million USD 68.376%
Vaccinex, Inc. 26 Thousand USD -16030.769%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. - USD -Infinity%